- Home
- ZEPP vs KRON Comparison
ZEPP vs KRON Comparison
Compare ZEPP & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- KRON
- Stock Information
- Founded
- ZEPP 2013
- KRON 2017
- Country
- ZEPP Netherlands
- KRON United States
- Employees
- ZEPP N/A
- KRON N/A
- Industry
- ZEPP Computer Manufacturing
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ZEPP Technology
- KRON Health Care
- Exchange
- ZEPP Nasdaq
- KRON Nasdaq
- Market Cap
- ZEPP 37.1M
- KRON 41.0M
- IPO Year
- ZEPP N/A
- KRON 2020
- Fundamental
- Price
- ZEPP $2.36
- KRON $0.67
- Analyst Decision
- ZEPP
- KRON Buy
- Analyst Count
- ZEPP 0
- KRON 3
- Target Price
- ZEPP N/A
- KRON $1.63
- AVG Volume (30 Days)
- ZEPP 33.4K
- KRON 826.3K
- Earning Date
- ZEPP 05-19-2025
- KRON 06-10-2025
- Dividend Yield
- ZEPP N/A
- KRON N/A
- EPS Growth
- ZEPP N/A
- KRON N/A
- EPS
- ZEPP N/A
- KRON N/A
- Revenue
- ZEPP $181,183,000.00
- KRON $9,192,000.00
- Revenue This Year
- ZEPP $758.69
- KRON N/A
- Revenue Next Year
- ZEPP N/A
- KRON N/A
- P/E Ratio
- ZEPP N/A
- KRON N/A
- Revenue Growth
- ZEPP N/A
- KRON 21.16
- 52 Week Low
- ZEPP $2.06
- KRON $0.65
- 52 Week High
- ZEPP $4.38
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ZEPP 39.20
- KRON 33.35
- Support Level
- ZEPP $2.35
- KRON $0.66
- Resistance Level
- ZEPP $2.61
- KRON $0.75
- Average True Range (ATR)
- ZEPP 0.22
- KRON 0.03
- MACD
- ZEPP -0.03
- KRON 0.00
- Stochastic Oscillator
- ZEPP 18.05
- KRON 19.47
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.